Association analysis of Gprotein ␤3 subunit gene with altered Ca
2+ homeostasis in bipolar disorder
SIR -Substantial evidence implicates disturbances in G-protein-mediated signal transduction and calcium (Ca 2+ ) homeostasis in the pathophysiology of bipolar disorder (BD). [1] [2] [3] We have previously demonstrated increased basal intracellular calcium concentration, [Ca 2+ ] i , in B lymphoblast cell lines (BLCLs) from BD patients, 4 which may be trait-dependent and reflect a putative endophenotype of BD. While the pathophysiological bases of the Ca 2+ disturbances in BD remain largely unknown, abnormalities in G q -and/or G icoupled phosphoinositide signaling could be involved. 4 In addition to the noted alterations in the levels and function of G␣ s and G␣ q (reviewed in Li et al), 2 altered G␣ i mRNA abundance, immunolabeling and function have been observed in BD. Activation of PLC-␤ by released ␤␥ from the G␣ i ␤␥ heterotrimer leads to inositol 1,4,5-trisphosphate (IP 3 ) formation and subsequent release of Ca 2+ from the endoplasmic reticulum (ER) storage pools. 5 Thus, disturbances in G i -mediated transduction mechanisms could affect the phosphoinositide and Ca 2+ signaling systems in BD.
Of interest in this regard, a functional single nucleotide polymorphism (SNP) in the human G-protein ␤3 subunit gene (GNB3) is associated with an essential hypertensive (HT) phenotype of increased agoniststimulated [Ca 2+ ] i in BLCLs. 6 A C→ T transition (C825T) in exon 10 results in a shortened, more active, splice variant of the ␤3-subunit. 6 This upregulated Gprotein activity apparently leads to more efficient activation of PLC, increased IP 3 formation, and Ca 2+ release from ER stores that ultimately provokes cellular and vascular changes leading to HT.
In view of the effects of the GNB3 SNP on intracellular Ca 2+ regulation in HT, and the modest linkage between BD and loci on chromosome 12p13.3, 7 where GNB3 is located, we compared the genotype at the C825T locus in BD I patients showing 'high' or 'normal' basal BLCL [Ca 2+ ] i phenotypes with that in BD II, MDD or healthy subjects. We employed a case-control association study, to analyze both the contribution of genotype to the higher basal [Ca 2+ ] i phenotype, and any diagnostic specificity of association.
Patients and healthy subjects (total n = 166) were recruited and screened as previously described. 4 BLCL samples were analyzed matched by subject age, sex, and age of onset of psychiatric illness. BLCLs were established, and basal BLCL [Ca 2+ ] i determined by ratiometric fluorometry, as reported previously. 4 BD I patients whose BLCL basal [Ca 2+ ] i was у 1 SD above the mean of that determined in healthy subjects (57.1 ± 6.9 nM; n = 37) were classified as having a 'high' [Ca 2+ ] i cellular phenotype. Genomic DNA was extracted from BLCLs using a QIAmp ® Blood Kit (Qiagen, Mississauga, Ontario, Canada), and the SNP in exon 10 of the GNB3 gene was determined by RFLP as described. 6 A P value of 0.05 was taken to indicate statistical significance in all tests.
Demographics of the matched subjects showed a balanced sex ratio across diagnostic groups (F = 0.039, 4, 161 df, P = 1.0). An overall preponderance of female subjects reflected a random bias in our subject pool. Subject ages were not significantly different among diagnostic groups (F = 0.544, 4, 161 df, P = 0.70), but ages of onset differed (F = 5.51, 3, 114 df, P = 0.001), due to a later mean age of onset for the MDD group, as is characteristic of that disorder. The ages of onset of the three BD groups were similar (F = 0.145, 2, 97 df, P = 0.86). possibility that this gene represents a risk or vulnerability factor cannot yet be completely ruled out. It has recently been proposed that, in any diseased population, the presence of HW disequilibrium for a given set of alleles suggests an association of one or more of those alleles with the disease. 8 We showed HW disequilibrium for GNB3 C825T in MDD patients and a trend in BD II patients, suggesting a putative role of this gene in susceptibility to these disorders, but not in susceptibility to the high [Ca 2+ ] i BD I phenotype as originally hypothesized. However, it must be cautioned that the lack of any MDD patients genotyped as TT in this study could well be a random experimental bias, and not indicative of real disequilibrium.
The [Ca 2+ ] i in BD I high [Ca 2+ ] i patients with the TT genotype is significantly higher than that of the other patients in the high [Ca 2+ ] i diagnostic group, suggesting a role for the GNB3 C825T functional SNP in causing increased basal [Ca 2+ ] i in some BD I patients exhibiting this phenotype. However, this conclusion can only be tentative, since the statistical power of all the analyses is low (ranging from 19-58%), as a result of the relatively small number of subjects studied. The results may also have been confounded to some degree due to ethnic stratification of the experimental population, 9 despite attempted randomization. However, it may be tentatively asserted that selection of BD patients based on the putative cellular endophenotype used here may help to minimize ethnic stratification effects. Since the relationship between the SNP and the increased basal [Ca 2+ ] i endophenotype in BD remains unclear, further work is indicated, such as sib-pair analyses, or association studies with larger cohorts.
We have described a method of seeking association between the putative high basal [Ca 2+ ] i cellular endophenotype identified in BD 4 and a candidate gene expressing a known functional variant with distinct effects that could account for this endophenotype. This novel method combines the statistical power of hypothesis-based testing, as opposed to genome scans, 10 with the additional benefit of minimizing the confounding effect of phenotypic heterogeneity in psychiatric diagnoses. Although we found no significant association between the GNB3 C825T polymorphism and altered Ca 2+ homeostasis in BD, we did identify a potential effect of this polymorphism in increasing basal [Ca 2+ ] i amongst BD patients displaying a 'high' [Ca 2+ ] i endophenotype. This intriguing result suggests that our endophenotype strategy is a promising approach, to seek out genetic factors in BD.
